Cinacalcet Impurity 9, with the CAS number 1298419-35-8, is a chemical compound that is recognized as an impurity associated with the synthesis of cinacalcet, a medication used to treat secondary hyperparathyroidism in patients with chronic kidney disease. While specific characteristics such as molecular weight, melting point, and solubility may vary, impurities like this typically exhibit structural similarities to the parent compound, which can influence their chemical behavior and stability. Impurities are often characterized by their potential effects on the efficacy and safety of the primary drug, necessitating thorough analysis during pharmaceutical development. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities. Understanding the properties of Cinacalcet Impurity 9 is crucial for ensuring the quality and safety of cinacalcet formulations, as well as for regulatory compliance in pharmaceutical manufacturing.

Cinacalcet Impurity 9

1298419-35-8: Cinacalcet Impurity 9, with the CAS number 1298419-35-8, is a chemical compound that is recognized as an impurity associated with the synthesis of cinacalcet, a medication used to treat secondary hyperparathyroidism in patients with chronic kidney disease. While specific characteristics such as molecular weight, melting point, and solubility may vary, impurities like this typically exhibit structural similarities to the parent compound, which can influence their chemical behavior and stability. Impurities are often characterized by their potential effects on the efficacy and safety of the primary drug, necessitating thorough analysis during pharmaceutical development. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities. Understanding the properties of Cinacalcet Impurity 9 is crucial for ensuring the quality and safety of cinacalcet formulations, as well as for regulatory compliance in pharmaceutical manufacturing.

CAS 1298419-35-8

Cinacalcet Impurity 9

N-[1-(1-Naphthalenyl)ethyl]-4-nitrobenzenesulfonamide

Ref: TR-N359255

Cinacalcet Impurity 47

Ref: ST-EA-CP-C21065